| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.
Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 190.3K | - | - | |
| Other | 51.8K | $1.04M | - | |
| CFO | 39.9K | $651.7K | - | |
| Other | 37.0K | $725.6K | - | |
| Other | 32.6K | $426.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale+OE | 12,394 | $16.33 | $202,437.40 | -23.7% | - | - | |
| Sep 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale+OE | 10,185 | $17.62 | $179,456.64 | -20.3% | - | - | |
| Aug 28, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 679 | $20.00 | $13,580.00 | -1.3% | - | - | |
| Aug 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale+OE | 72,725 | $19.94 | $1,450,419.25 | -64.6% | - | - | |
| Aug 17, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 1,000 | $20.00 | $20,000.00 | -1.9% | - | - | |
| Aug 11, 2026 | Riley Jennifer | Chief Strategy Officer | Sell | 2,655 | $19.59 | $52,012.25 | -6.7% | - | - | |
| Aug 10, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 679 | $20.00 | $13,580.00 | -1.3% | - | - | |
| Jul 27, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 1,000 | $20.00 | $20,000.00 | -1.9% | - | - | |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 4,654 | $20.00 | $93,080.00 | -8.2% | - | - | |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 1,450 | $18.00 | $26,100.00 | -2.7% | - | - |